Does a 3D model predict treatment response better than CT for pancreatic cancer?
Part of Cancer clinical trials.
This study tests whether a special 3D scan can better tell if treatment has shrunk the tumor in people with pancreatic cancer. It may help your doctors decide if surgery is a good option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with borderline or locally advanced pancreatic cancer in the head of the pancreas.
- You have received treatment before surgery (neoadjuvant therapy).
- You are scheduled to have surgery to try to remove the tumor.
- You are 18 years or older.
- You had a CT scan before surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special MRI scan called 3D MRE to see how well people with pancreatic cancer might do. It looks at the stiffness of the tumor and surrounding tissue to help predict outcomes.
This study is testing a new way to make 3D models in the lab that look like your specific tumor. The goal is to better understand pancreatic neuroendocrine tumors and find personalized treatments.
This study builds a computer model to predict how well pancreatic cancer patients will respond to surgery and what their long-term outcomes might be. Researchers use CT scans, blood tests, and medical records from patients who had pancreatic cancer surgery to teach the model to recognize patterns that help predict outcomes.
This study is testing a new MRI technique that may help predict how well pancreatic cancer treatments will work. You would receive a special substance (called hyperpolarized pyruvate) during a standard MRI scan.
This study uses 3D imaging to help doctors plan surgery for locally advanced colon cancer. By creating a detailed model of your tumor and nearby structures, it may help the surgeon remove the cancer more precisely and safely. If you join, you will still receive standard surgery, but the preparation will include this 3D technology.
This trial tests a special imaging scan (a PET/CT with a tracer called 68Ga-FAPI-46) to look at “cancer-support” cells in people with localized pancreatic ductal adenocarcinoma. It may help doctors better understand the tumor and how it responds before surgery after initial treatment.
Hear when a new Adenocarcinoma of the Pancreas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.